Lazabemide hydrochloride
- Level
- Commodity
- Parent
- 51142500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142552This classification denotes a monoamine oxidase inhibitor C8H10ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PI150J9ZX1, chemically known as 2-pyridinecarboxamide, n-(2-aminoethyl)-5-chloro-, monohydrochloride, but more generally known as lazabemide hydrochloride, which bears US NIH Compound Identifier 163727. Most nations, for tariff and trade purposes, schedule lazabemide hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, LAZABEMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lazabemide hydrochloride bears US NLM identifiers UMLS ID C2825397 and NCI Concept Code C80968. SMILES: C1CC(NCC1CL)C(=O)NCCN.CL.
Same parent
Under 51142500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.